Science and Development Network
News, views and information about science, technology and the developing world
Source: DenverPost.com
4 November 2004 | EN
Rotavirus kills millions of children in developing countries each year
Bernard Osès/IRD
Harmful side effects of vaccination against rotavirus — which kills millions of children worldwide, mainly in developing countries — could be avoided with a new vaccine, say researchers. Unlike the previous vaccine, it does not create an increased risk of bowel blockage, a problem that led to its predecessor's withdrawal in the United States.
The findings were presented on 31 October at a meeting of the American Society for Microbiology. The vaccine, made by GlaxoSmithKline Biologicals, was tested in more than 63,000 infants in Latin America and Finland. Children who were vaccinated and those who received a placebo vaccine developed bowel blockages in equal proportions.
The new vaccine, known as Rotarix, has been licensed for use in Mexico. GlaxoSmithKline Biologicals aims to obtain licenses for its use in the rest of Latin America, Asia, and Europe. The company also intends to start trials in the United States.
Our blog, by SciDev.Net columnist Priya Shetty, will fill you in, as will our interview with the Global Forum's Gill Samuels
Countries must cooperate to develop clean technologies. Joint technology innovation centres can help
Will USAID’s likely new chief switch the focus from shipping food to growing it?
Policymakers must improve water storage to help developing countries adapt to climate change
Add your comment
All comments are subject to approval and we reserve the right to edit comments containing inappropriate/unsuitable language. SciDev.Net holds copyright for all material posted on the website. Please see terms of use for further details.
You need to be signed in to post a comment or to email a consenting comment author. Please sign in or sign up.